首页> 外文期刊>Cell death and differentiation >Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish
【24h】

Rip3 knockdown rescues photoreceptor cell death in blind pde6c zebrafish

机译:Rip3组合可挽救盲pde6c斑马鱼中的感光细胞死亡

获取原文
获取原文并翻译 | 示例
           

摘要

Achromatopsia is a progressive autosomal recessive retinal disease characterized by early loss of cone photoreceptors and later rod photoreceptor loss. In most cases, mutations have been identified in CNGA3, CNGB3, GNAT2, PDE6C or PDE6H genes. Owing to this genetic heterogeneity, mutation-independent therapeutic schemes aimed at preventing cone cell death are very attractive treatment strategies. In pde6c(w59) mutant zebrafish, cone photoreceptors expressed high levels of receptor-interacting protein kinase 1 (RIP1) and receptor-interacting protein kinase 3 (RIP3) kinases, key regulators of necroptotic cell death. In contrast, rod photoreceptor cells were alternatively immunopositive for caspase-3 indicating activation of caspase-dependent apoptosis in these cells. Morpholino gene knockdown of rip3 in pde6c(w59) embryos rescued the dying cone photoreceptors by inhibiting the formation of reactive oxygen species and by inhibiting second-order neuron remodelling in the inner retina. In rip3 morphant larvae, visual function was restored in the cones by upregulation of the rod phosphodiesterase genes (pde6a and pde6b), compensating for the lack of cone pde6c suggesting that cones are able to adapt to their local environment. Furthermore, we demonstrated through pharmacological inhibition of RIP1 and RIP3 activity that cone cell death was also delayed. Collectively, these results demonstrate that the underlying mechanism of cone cell death in the pde6c(w59) mutant retina is through necroptosis, whereas rod photoreceptor bystander death occurs through a caspase-dependent mechanism. This suggests that targeting the RIP kinase signalling pathway could be an effective therapeutic intervention in retinal degeneration patients. As bystander cell death is an important feature of many retinal diseases, combinatorial approaches targeting different cell death pathways may evolve as an important general principle in treatment.
机译:色盲症是一种进行性常染色体隐性遗传性视网膜疾病,其特征是视锥光感受器的早期丧失和视杆光感受器的丧失。在大多数情况下,已在CNGA3,CNGB3,GNAT2,PDE6C或PDE6H基因中鉴定出突变。由于这种遗传异质性,旨在防止视锥细胞死亡的与突变无关的治疗方案是非常有吸引力的治疗策略。在pde6c(w59)突变斑马鱼中,视锥细胞感光细胞表达高水平的受体相互作用蛋白激酶1(RIP1)和受体相互作用蛋白激酶3(RIP3)激酶,是坏死性细胞死亡的关键调节因子。相反,杆状感光细胞对caspase-3的免疫反应为阳性,表明这些细胞中caspase依赖性细胞凋亡的激活。 pde6c(w59)胚胎中rip3的吗啉基因敲低通过抑制活性氧的形成并抑制内视网膜的二级神经元重构来拯救垂死的视锥细胞感光细胞。在rip3变体幼虫中,视杆中磷酸二酯酶基因(pde6a和pde6b)的上调恢复了视锥的视觉功能,弥补了视锥pde6c的缺乏,提示视锥能够适应其局部环境。此外,我们通过药理学抑制RIP1和RIP3活性证明锥细胞死亡也被延迟。总的来说,这些结果表明pde6c(w59)突变体视网膜中视锥细胞死亡的潜在机制是通过尸检,而杆状光感受器旁观者死亡是通过caspase依赖性机制发生的。这表明靶向RIP激酶信号通路可能是视网膜变性患者的有效治疗干预。由于旁观者细胞死亡是许多视网膜疾病的重要特征,针对不同细胞死亡途径的组合方法可能会演变为治疗中的重要一般原则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号